CVS Health is trading 8.1% down now at $95.97 as early gains from strong Q2 2026 results and raised full-year guidance evaporate.

  • The stock initially surged in pre-market trading following the positive earnings report and improved annual outlook.
  • Investors appear to be reassessing the results and a prior multi-day rally, leading to a reversal even as the broader healthcare sector trades higher.